Neural Network Learns to Select Potential Anticancer Drugs

www.dddmag.com

Scientists from Mail.Ru Group, Insilico Medicine and MIPT have for the first time applied a generative neural network to create new pharmaceutical medicines with the desired characteristics. By using Generative Adversarial Networks (GANs) developed and trained to "invent" new molecular structures, there may soon be a dramatic reduction in the time and cost of searching for substances with potential medicinal properties. 

Read more...
Linkedin

Want to receive more content like this in your inbox?